| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
570,750,000 |
| Market
Cap: |
76.54(M) |
| Last
Volume: |
3,709,408 |
Avg
Vol: |
3,188,549 |
| 52
Week Range: |
$0.1356 - $0.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kelly Scott A. |
CMO |
• • – |
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,950 |
2,080,761 |
|
- |
|
| Ray Nitya G. |
Chief Technology Officer |
• – – |
2022-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,102 |
418,818 |
|
- |
|
| Kelly Scott A. |
CMO |
• • – |
2022-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,492 |
2,073,811 |
|
- |
|
| Migliarese Antonio |
CFO & Interim President |
• – – |
2022-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,614 |
106,955 |
|
- |
|
| Kelly Scott A. |
CMO |
• • – |
2022-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,112 |
2,066,319 |
|
- |
|
| Ray Nitya G. |
Chief Technology Officer |
• – – |
2022-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,428 |
411,716 |
|
- |
|
| Migliarese Antonio |
CFO & Interim President |
• – – |
2022-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,824 |
101,341 |
|
- |
|
| Ray Nitya G. |
Chief Technology Officer |
• – – |
2022-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,020 |
399,288 |
|
- |
|
| Kelly Scott A. |
CMO |
• • – |
2022-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,736 |
2,053,207 |
|
- |
|
| Migliarese Antonio |
CFO & Interim President |
• – – |
2022-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,292 |
91,517 |
|
- |
|
| Migliarese Antonio |
CFO & Interim President |
• – – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,807 |
81,225 |
|
- |
|
| Ray Nitya G. |
Chief Technology Officer |
• – – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,671 |
386,268 |
|
- |
|
| Kelly Scott A. |
CMO |
• • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
14,423 |
2,039,471 |
|
- |
|
| Migliarese Antonio |
CFO & Interim President |
• – – |
2022-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,509 |
70,448 |
|
- |
|
| Ray Nitya G. |
Chief Technology Officer |
• – – |
2022-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,089 |
372,597 |
|
- |
|
| Kelly Scott A. |
CMO |
• • – |
2022-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
18,029 |
2,025,048 |
|
- |
|
| Migliarese Antonio |
CFO & Interim President |
• – – |
2022-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,714 |
56,939 |
|
- |
|
| Ray Nitya G. |
Chief Technology Officer |
• – – |
2022-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,084 |
355,508 |
|
- |
|
| Kelly Scott A. |
CMO |
• • – |
2022-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,968 |
2,007,019 |
|
- |
|
| Migliarese Antonio |
CFO & Interim President |
• – – |
2022-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,509 |
44,225 |
|
- |
|
| Ray Nitya G. |
Chief Technology Officer |
• – – |
2022-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
17,089 |
339,424 |
|
- |
|
| Kelly Scott A. |
CMO |
• • – |
2022-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,029 |
1,990,051 |
|
- |
|
| Migliarese Antonio |
CFO & Interim President |
• – – |
2022-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,010 |
30,716 |
|
- |
|
| Recknor Chris P |
See Remarks |
• – – |
2022-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,746 |
716,746 |
|
- |
|
| Ray Nitya G. |
Chief Technology Officer |
• – – |
2022-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,254 |
322,335 |
|
- |
|
381 Records found
|
|
Page 2 of 16 |
|
|
